Clinical Trials Directory

Trials / Sponsors / UCB Pharma SA

UCB Pharma SA

Industry · 28 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Study of Certolizumab Pegol to Evaluate Pharmacokinetics and Safety in Adult Healthy Chinese Subjects
Healthy Subjects
Phase 12015-03-01
CompletedAn Open-label Extension Study of Certolizumab Pegol in Chinese Patients With Rheumatoid Arthritis Who Enrolled
Rheumatoid Arthritis
Phase 32014-11-01
CompletedSingle-site, Open-label, Randomized, Cross-over Study in Healthy Chinese Subjects to Evaluate the Bioequivalen
Healthy
Phase 12014-02-01
CompletedBioavailability/Bioequivalence Study Between Lacosamide Tablet and Solution for Infusion in Healthy Japanese S
Healthy Volunteers
Phase 12013-11-01
CompletedOpen-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seiz
Epilepsy, Partial Seizures
Phase 32013-09-01
CompletedStudy to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Ad
Epilepsy, Partial-onset Seizures
Phase 32013-03-26
CompletedComparison of Brivaracetam Oral Tablet (10 mg, 50 mg, 75 mg and 100 mg) and Brivaracetam Injection (100 mg) in
Healthy Volunteers
Phase 12013-01-01
CompletedNoninterventional Examination of Subcutaneous (sc) Tumor Necrosis Factor (TNF) Inhibitors
Rheumatoid Arthritis
2012-12-01
CompletedEvaluation of Long-term Safety, and Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects Wi
Epilepsy
Phase 32012-10-01
CompletedA Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset
Epilepsy, Partial Onset Seizures
Phase 32012-09-01
CompletedA Study to Investigate the Drug-Drug Interactions of Brivaracetam and Ethanol in Healthy Male Subjects
Healthy Volunteers
Phase 12012-09-01
CompletedEffect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levet
Epilepsy
Phase 32012-07-01
TerminatedSleep Efficiency Assessed by Polysomnography (PSG Sleep Lab Testing) in Advanced Parkinson's Disease
Advanced Idiopathic Parkinson's Disease
Phase 42012-03-01
CompletedHealth-related Quality of Life and Patient-reported Outcomes in Rheumatoid Arthritis Patients Treated With Cer
Rheumatoid Arthritis
2012-01-01
CompletedA Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Cert
Rheumatoid Arthritis
Phase 32012-01-01
CompletedStudy to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimum
Rheumatoid Arthritis
Phase 42011-12-01
CompletedOpen-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy
Epilepsy
Phase 32011-08-01
CompletedOpen-label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy
Epilepsy
Phase 22008-05-01
CompletedBrivaracetam as add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Epilepsy
Phase 32007-10-01
CompletedDouble-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset
Epilepsy
Phase 32007-09-01
CompletedBrivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and Adults
Unverricht-Lundborg Disease
Phase 32006-11-01
CompletedExploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes
Narcolepsy With Cataplexy
Phase 12006-04-10
CompletedStudy With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam
Epilepsy, Partial
Phase 22005-08-31
CompletedMonotherapy With Levetiracetam in Patients Suffering From Epilepsy.
Epilepsy, Tonic-clonic
Phase 32005-08-10
CompletedA follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double B
Crohn's Disease
Phase 32004-07-01
CompletedA follow-on Safety Study in Subjects With Crohn's Disease Who Have Previously Been Withdrawn From the Double-b
Crohn's Disease
Phase 32004-02-01
CompletedPrevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema
Dermatitis, Atopic
Phase 32002-03-20
CompletedLong Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy
Generalized Epilepsy
Phase 32001-11-01